Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus.

Payne, Jennifer A E; Tailhades, Julien; Ellett, Felix; Kostoulias, Xenia; Fulcher, Alex J; Fu, Ting; Leung, Ryan; Louch, Stephanie; Tran, Amy; Weber, Severin A; Schittenhelm, Ralf B; Lieschke, Graham J; Qin, Chengxue Helena; Irima, Daniel; Peleg, Anton Y; Cryle, Max J

Payne, Jennifer A E; Tailhades, Julien; Ellett, Felix; Kostoulias, Xenia; Fulcher, Alex J; Fu, Ting; Leung, Ryan; Louch, Stephanie; Tran, Amy; Weber, Severin A; Schittenhelm, Ralf B; Lieschke, Graham J; Qin, Chengxue Helena; Irima, Daniel; Peleg, Anton Y; Cryle, Max J.

Affiliation

Payne JAE; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia. jennifer.payne@monash.edu.
Tailhades J; ARC Centre of Excellence for Innovations in Peptide and Protein Science, Monash University, Clayton, Victoria, 3800, Australia. jennifer.payne@monash.edu.
Ellett F; EMBL Australia, Monash University, Clayton, Victoria, 3800, Australia. jennifer.payne@monash.edu.
Kostoulias X; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia.
Fulcher AJ; ARC Centre of Excellence for Innovations in Peptide and Protein Science, Monash University, Clayton, Victoria, 3800, Australia.
Fu T; EMBL Australia, Monash University, Clayton, Victoria, 3800, Australia.
Leung R; BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Massachusetts General Hospital, Shriners Hospital for Children, and Harvard Medical School, Charlestown, MA, 02129, USA.
Louch S; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria, 3800, Australia.
Tran A; Monash Micro Imaging, Monash University, Clayton, Victoria, 3800, Australia.
Weber SA; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.
Schittenhelm RB; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia.
Lieschke GJ; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia.
Qin CH; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia.
Irima D; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia.
Peleg AY; EMBL Australia, Monash University, Clayton, Victoria, 3800, Australia.
Cryle MJ; Monash Proteomics and Metabolomics Facility, Monash University, Clayton, Victoria, 3800, Australia.

Nat Commun ; 12(1): 6157, 2021 10 25.

Article de En | MEDLINE | ID: mdl-34697316

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Staphylococcus aureus / Facteurs chimiotactiques / Antibactériens / Granulocytes neutrophiles Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2021 Type de document: Article Pays d'affiliation: Australie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google